BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee Y, Raviglione MC, Flahault A. Use of Digital Technology to Enhance Tuberculosis Control: Scoping Review. J Med Internet Res 2020;22:e15727. [PMID: 32053111 DOI: 10.2196/15727] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Burzynski J, Mangan JM, Lam CK, Macaraig M, Salerno MM, deCastro BR, Goswami ND, Lin CY, Schluger NW, Vernon A, Bamrah-morris S, Bowers S, Carberry S, Chuck C, Dias M, Gao G, Garfein R, Green V, Gross L, Henry G, Hill A, Kiskadden-bechtel S, Lakshman M, Mitropoulos N, Nilsen DM, Oxtoby M, Philips P, Reaves M, Robinson E, Sathi C, Stewart B, Thomas A, Tolochko Z, Trieu L, Winston C; eDOT Study Team. In-Person vs Electronic Directly Observed Therapy for Tuberculosis Treatment Adherence: A Randomized Noninferiority Trial. JAMA Netw Open 2022;5:e2144210. [DOI: 10.1001/jamanetworkopen.2021.44210] [Reference Citation Analysis]
2 Paleckyte A, Dissanayake O, Mpagama S, Lipman MC, McHugh TD. Reducing the risk of tuberculosis transmission for HCWs in high incidence settings. Antimicrob Resist Infect Control 2021;10:106. [PMID: 34281623 DOI: 10.1186/s13756-021-00975-y] [Reference Citation Analysis]
3 Tumuhimbise W, Musiimenta A. A review of mobile health interventions for public private mix in tuberculosis care. Internet Interv 2021;25:100417. [PMID: 34401376 DOI: 10.1016/j.invent.2021.100417] [Reference Citation Analysis]
4 Nguyen VL, Ahn S, Hoa PQ, Long NP, Ahn S, Cho Y, Shin J. Center for Personalized Precision Medicine for Tuberculosis: Smart Research and Development Workstation. Healthc Inform Res 2022;28:176-80. [DOI: 10.4258/hir.2022.28.2.176] [Reference Citation Analysis]
5 Makabayi-mugabe R, Musaazi J, Zawedde-muyanja S, Kizito E, Namwanje H, Aleu P, Charlet D, Freitas Lopez DB, Brightman H, Turyahabwe S, Nkolo A. Developing a patient-centered community-based model for management of multi-drug resistant tuberculosis in Uganda: a discrete choice experiment. BMC Health Serv Res 2022;22. [DOI: 10.1186/s12913-021-07365-5] [Reference Citation Analysis]
6 Milligan H, Iribarren SJ, Chirico C, Telles H, Schnall R. Insights from participant engagement with the tuberculosis treatment support tools intervention: Thematic analysis of interactive messages to guide refinement to better meet end user needs. Int J Med Inform 2021;149:104421. [PMID: 33706032 DOI: 10.1016/j.ijmedinf.2021.104421] [Reference Citation Analysis]
7 Harries AD, Kumar AMV, Satyanarayana S, Thekkur P, Lin Y, Dlodlo RA, Khogali M, Zachariah R. The Growing Importance of Tuberculosis Preventive Therapy and How Research and Innovation Can Enhance Its Implementation on the Ground. Trop Med Infect Dis 2020;5:E61. [PMID: 32316300 DOI: 10.3390/tropicalmed5020061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Gray AT, Wood CE, Boyles T, Luedtke S, Birjovanu G, Hughes J, Kostkova P, Esmail H. Following Guidelines for Drug-Resistant Tuberculosis: “Yes, it’s a challenge”. Front Trop Dis 2021;2:645933. [DOI: 10.3389/fitd.2021.645933] [Reference Citation Analysis]
9 Owais M, Arsalan M, Mahmood T, Kim YH, Park KR. Comprehensive Computer-Aided Decision Support Framework to Diagnose Tuberculosis From Chest X-Ray Images: Data Mining Study. JMIR Med Inform 2020;8:e21790. [PMID: 33284119 DOI: 10.2196/21790] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 De Angelis M, Lavorgna L, Carotenuto A, Petruzzo M, Lanzillo R, Brescia Morra V, Moccia M. Digital Technology in Clinical Trials for Multiple Sclerosis: Systematic Review. J Clin Med 2021;10:2328. [PMID: 34073464 DOI: 10.3390/jcm10112328] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Ragan EJ, Gill CJ, Banos M, Bouton TC, Rooney J, Horsburgh CR, Warren RM, Myers B, Jacobson KR. Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study. JMIR Res Protoc 2021;10:e24510. [PMID: 34132642 DOI: 10.2196/24510] [Reference Citation Analysis]
12 Munteanu I, Cioran N, van Hest R, Abubakar I, Story A, Chiotan D, de Vries G, Mahler B. Tuberculosis Surveillance in Romania Among Vulnerable Risk Groups Between 2015 and 2017. TCRM 2022;Volume 18:439-46. [DOI: 10.2147/tcrm.s347748] [Reference Citation Analysis]
13 Thapa P, Jayasuriya R, Hall JJ, Beek K, Mukherjee P, Gudi N, Narasimhan P. Role of informal healthcare providers in tuberculosis care in low- and middle-income countries: A systematic scoping review. PLoS One 2021;16:e0256795. [PMID: 34473752 DOI: 10.1371/journal.pone.0256795] [Reference Citation Analysis]
14 de Groot LM, Straetemans M, Maraba N, Jennings L, Gler MT, Marcelo D, Mekoro M, Steenkamp P, Gavioli R, Spaulding A, Prophete E, Bury M, Banu S, Sultana S, Onjare B, Efo E, Alacapa J, Levy J, Morales MLL, Katamba A, Bogdanov A, Gamazina K, Kumarkul D, Ekaterina O, Cattamanchi A, Khan A, Bakker MI. Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies—An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries. TropicalMed 2022;7:65. [DOI: 10.3390/tropicalmed7050065] [Reference Citation Analysis]
15 Gadicherla S, Krishnappa L, Madhuri B, Mitra SG, Ramaprasad A, Seevan R, Sreeganga SD, Thodika NK, Mathew S, Suresh V. Envisioning a learning surveillance system for tuberculosis. PLoS One 2020;15:e0243610. [PMID: 33315902 DOI: 10.1371/journal.pone.0243610] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]